FDA allows compounders to repackage, combine propofol amid Covid-19
After allowing compounders and outsourcing facilities to compound 13 drugs needed to treat patients on ventilators during the coronavirus disease (Covid-19) public health emergency, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.